Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma.
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.|Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland.
Leo
L
Meriranta
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.|Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland.
Annika
A
Pasanen
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.
Riku
R
Louhimo
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.
Alejandra
A
Cervera
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.
Amjad
A
Alkodsi
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.|Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland.
Matias
M
Autio
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.|Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland.
Minna
M
Taskinen
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.
Ville
V
Rantanen
Department of Pathology, Helsinki University Hospital, Finland.
Marja-Liisa
ML
Karjalainen-Lindsberg
Department of Oncology, Oslo University Hospital, Norway.
Harald
H
Holte
Department of Pathology, University of Toronto, ON, Canada.|Department of Pathology, Oslo University Hospital, Norway.
Jan
J
Delabie
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.
Rainer
R
Lehtonen
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland.
Sampsa
S
Hautaniemi
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland sirpa.leppa@helsinki.fi.|Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland.
Sirpa
S
Leppä
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor; D004252:DNA Mutational Analysis; D005091:Exons; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000235:genetics* / Q000401:mortality* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D011379:Prognosis; D016016:Proportional Hazards Models; D000072417:Protein Domains / Q000235:genetics; D044767:Ubiquitin-Protein Ligases / Q000737:chemistry / Q000235:genetics*
D014408:Biomarkers, Tumor; C583410:DTX1 protein, human; D044767:Ubiquitin-Protein Ligases